Trimas TRS Property, plant, and equipment additions

Property, plant, and equipment additions at other companies

West Pharmaceutical ServicesWST

——

Packaging$3.76M-52.9%

Specialty Products$1.43M+34.9%

Corporate Segment$490K-65.2%

Revenue$168.3M+10.4%

Gross profit$36.9M+12.3%

Operating income$6.9M-3.6%

Net income$800.8M+6,348%

EPS (diluted)$21.40+7,033%

Cash & equivalents$1.3B+3,904%

Total debt$439.9M-9.2%

Total equity$1.4B+111%

Total assets$2.3B+64.8%

Operating cash flow-$19.4M-311%

CapEx$5.2M-59.7%

Free cash flow-$24.6M-556%

Market cap$1.56B+41.9%

Enterprise value$692.33M-65.6%

P/E1.7×-33.2×

P/S2.4×+0.6×

Gross margin-0.1%-2.1pp

Operating margin8%-1.0pp

Net margin137.3%+132pp

FCF margin7.3%+3.1pp

Return on equity85.1%+80.4pp

Debt / equity0.3×-0.4×

Current ratio4.9×+2.0×